Comparing Butalbital Compound vs Ubrelvy
Butalbital Compound (aspirin / butalbital / caffeine) | Ubrelvy (ubrogepant) |
|
---|
Butalbital Compound (aspirin / butalbital / caffeine) | Ubrelvy (ubrogepant) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Headache, Migraine, Pain. Butalbital Compound may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy is a prescription medicine that may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine... View more |
Related suggestions Migraine
|
|||||||
More about (aspirin / butalbital / caffeine) | More about Ubrelvy (ubrogepant) | ||||||||
Ratings & Reviews | |||||||||
Butalbital Compound has an average rating of 9.0 out of 10 from a total of 28 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ubrelvy has an average rating of 6.4 out of 10 from a total of 265 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Butalbital Compound side effects |
View all Ubrelvy side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic approved | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ubrelvy prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Other aspirin / butalbital / caffeine brands include: Farbital, Fiorinal, Fiormor, Fiortal, Fortabs |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
35 hours |
7 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 887 drugs are known to interact with Butalbital Compound:
|
A total of 247 drugs are known to interact with Ubrelvy:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
|
|||||||||
First Approval Date | |||||||||
N/A |
December 23, 2019 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
N/A |
|||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.